Much has been learned over a short period of time with respect to the corrosion assessment of small medical implant devices. Laboratory testing started with modifications of ASTM G 5 and G 61, which lead to the development of ASTM F 2129, and thence the fine-tuning of that specification to meet the intent of the FDA Guideline for non-clinical tests. The changes in electrochemical testing protocol with time are reviewed. Comparative data is presented addressing test environments, scan rates, statistical replication, alloy response, and acceptance criteria.

Subject
Test methods, Materials, Materials performance, Repassivation potentials, Potential range, Open circuits, Equipment, Pitting, Corrosion resistance, Electrochemical potential, Rest potential, Breakdown potential, Electrode potential
Keywords:
ASTM F 2129, pitting corrosion, cyclic potentiodynamic polarization, in vitro testing
© 2007 Association for Materials Protection and Performance (AMPP). All rights reserved. No part of this publication may be reproduced, stored in a retrieval system, or transmitted, in any form or by any means (electronic, mechanical, photocopying, recording, or otherwise) without the prior written permission of AMPP. Positions and opinions advanced in this work are those of the author(s) and not necessarily those of AMPP. Responsibility for the content of the work lies solely with the author(s).
2007
Association for Materials Protection and Performance (AMPP)
You do not currently have access to this content.